Eflapegrastim - CAS 1384099-30-2

Eflapegrastim, a humanized IgG4 monoclonal antibody and granulocyte colony-stimulating factor (G-CSF), targets the G-CSF receptor (c-Fms) . It promotes the proliferation and differentiation of neutrophil progenitor cells, ensuring a stable count of mature and functional neutrophils, and effectively shortens the duration of neutropenia [1].

C-Fms

Tyrosine Kinase/Adaptors

1384067

-20°C

Ice Packs

Inhibitory Antibodies